News•Mar 9, 2026
European Survey Highlights Gaps in Care for Women with Hormonal Migraine
A European Migraine and Headache Alliance survey of 5,410 women revealed major gaps in diagnosing and treating hormonally linked migraine. Forty‑two percent of respondents had never received a formal diagnosis, and 35% reported that doctors never discussed their symptoms. While two‑thirds noticed a menstrual pattern, only 16% rated their current therapies as very effective, and 68% had never been offered hormone‑specific treatment. Women who received personalized management reported higher satisfaction, underscoring a clear unmet need.
By ACNR (Advances in Clinical Neuroscience & Rehabilitation)
News•Mar 6, 2026
MIT Researchers Develop Self-Implanting Nanotech Brain Devices
MIT Media Lab researchers have created subcellular‑sized wireless bioelectronic devices, termed “circulatronics,” that hitch a ride on monocytes to traverse the bloodstream, cross the blood‑brain barrier, and autonomously implant in inflamed brain tissue. In mouse studies the implants self‑positioned, were...
By ACNR (Advances in Clinical Neuroscience & Rehabilitation)
News•Mar 4, 2026
New Research Findings Challenge Old Beliefs About Myelin Repair in MS
Researchers using advanced imaging in mice discovered that oligodendrocyte precursor cells continuously differentiate into mature oligodendrocytes across the brain and spinal cord, regardless of myelin injury. This overturns the long‑standing belief that these cells only mature in response to damage....
By ACNR (Advances in Clinical Neuroscience & Rehabilitation)
News•Mar 2, 2026
Champion Insights Opens Nationwide Enrolment to Study ALS Risk in High-Performance Groups
Champion Insights has launched a nationwide enrollment to recruit up to 500 elite athletes, military veterans and first responders for a study investigating their elevated risk of amyotrophic lateral sclerosis (ALS). The remote study will collect blood samples and online...
By ACNR (Advances in Clinical Neuroscience & Rehabilitation)
News•Feb 27, 2026
Cure Parkinson’s Expands Its Research Committee and Welcomes New Interns
Cure Parkinson’s has expanded its Research Committee by adding eight new members from leading UK and European institutions, spanning neurology, bioinformatics, pharmacology and more. The charity also welcomed three early‑career researchers as interns, extending the programme beyond the UK to...
By ACNR (Advances in Clinical Neuroscience & Rehabilitation)
News•Feb 25, 2026
Five-Year Data Show Sustained Benefits with Briumvi in Relapsing MS
Long‑term data from the Phase 3 ULTIMATE I and II trials show that continuous treatment with Briumvi (ublituximab) provides sustained clinical benefits for relapsing multiple sclerosis over five years. More than 80 % of patients who started Briumvi remained free of relapses and...
By ACNR (Advances in Clinical Neuroscience & Rehabilitation)